arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Outset Medical, Inc.

OM
$3.12 ▼ -0.15 (-4.74%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
32 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Outset Medical, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth 0.7%
Op. Margin -49.6%
ROIC -8.2%
FCF / Share None
Trailing P/E
Price / Book 0.6x
FCF Yield
Debt / Equity 1.01
info Valuation on last close. End-of-day price, Sep 23, 2026.

32-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$31.64M
↑ +0.7%
Net Income Profit after all expenses
$-18.98M
↑ +26.4%
Operating Margin Operating profit as % of sales
-49.6%
↑ +18.4% 5th
FCF / Share Free cash flow per share
$-0.92
↑ +85.3%
Long-Term Debt Long-term obligations
$97.65M
↑ +0.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
5
Returns
14
Financial Health
37
Cash Quality
43

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 9 years · 32 quarters